Key statistics
Market cap
BDT 1,847.76 mn
Free float market cap
BDT 1,196.01 mn
NAV per share
BDT 23.02
P/E (audited)
43.41x
Day's value
BDT 8.3 mn
Day's volume
467,738
Day's trades
360
Opening price
BDT 18.20
Adjusted Opening Price
BDT 18.20
Last Update
02:09:32 PM
Day's range
Current BDT 17.80
BDT 17.60BDT 18.40
52-week range
Current BDT 17.80
BDT 11.10BDT 23.30
Basics
- Listing year
- 2019
- Authorized Capital (mn)
- BDT 1,050
- Paid-up capital
- BDT 1,038.07 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 103,807,000
- Market Lot
- 1
Shareholding pattern
as on Jun 30, 2025 (year ended)
as on Jun 30, 2026
as on Jul 31, 2026
Sponsor / Director
35.46%
35.27%
35.27%
Government
0.00%
0.00%
0.00%
Institution
16.97%
19.66%
17.32%
Foreign
0.00%
0.00%
0.00%
Public
47.57%
45.07%
47.41%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- 41 Nurani, Bankalapara, Subid Bazar, Sylhet
- Factory Address
- BSCIC, Industrial Estate, Khadim Nagar, Sylhet-3103.
- Contact Phone
- +880-02996638241
- Fax
- —
- info@silcopharma.com
- Company Secretary Name
- Mr. Tingku Ranjan Sarker
- Company Secretary Cell No.
- 8801716394060
- Company Secretary Telephone No.
- +880-02 996638241
- Company Secretary E-mail
- trt.tinku@gmail.com
- Website
- http://www.silcopharma.com/
- Loan status
- Short-term: — · Long-term: —
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 19-01-2026
- Year-end
- June
Details of Financial Statementsilcopharma.com/wp-content/uploads/2025/01/Annual-Audited-Financial-Statements-23-24.pdf
Price Sensitive Informationhttp://Price Sensitive Information (PSI) - Silco Pharmaceuticals Limited